-
Net profit of 858 million euros
Time of Update: 2023-01-25
First Choice Ingredients, a supplier of savory flavourings, helps DSM reach a wider range of food and beverages, including plant-based alternatives In order to integrate the advantages of all parties to improve the level of science and technology, DSM completed a series of acquisitions in 2021, including Amyris's flavor and fragrance bio-based intermediates business, Midori, a biotechnology start-up that develops targeted health products for animals, and dairy products.
-
The fungicide pentachloronitrobenzene (PCNB) is about to be banned in the United States
Time of Update: 2023-01-07
Recently, the US Environmental Protection Agency (US EPA) published a proposed decision on Pentachloronitrobenzene (PCNB), recommending that all registrations of the pesticide be canceled.
Recently, the US Environmental Protection Agency (US EPA) published a proposed decision on Pentachloronitrobenzene (PCNB), recommending that all registrations of the pesticide be canceled.
-
Peruvian official: Do not drink two drinks containing methanol in Punto D Oro
Time of Update: 2022-10-19
Recently, the General Directorate of Environmental Health and Food Safety (Digesa) of the Ministry of Health of Peru (Minsa) issued a warning to consumers not to buy or drink two alcoholic beverages under the "Punto D Oro" brand, because methanol is detected in their ingredients, which can cause serious damage to consumers' health after drinking.
-
Professor Zhi Xiuyi: The gains and losses of early screening for lung cancer under the new crown shroud
Time of Update: 2022-10-12
The small pulmonary nodules and suspected early lung cancer populations screened out by artificial intelligence technology, and then further clinical confirmation through the cooperation of multidisciplinary doctors such as imaging, thoracic surgery, respiratory and oncology, the work efficiency and diagnostic accuracy have been greatly improved.
-
Prof. Chun-Li Park: Focusing on the Management of the Whole Life Cycle of Diabetic Patients International Conference on Cyberpathology
Time of Update: 2022-09-30
Professor Park Chunli introduced that for more than 30 years, under the guidance of network disease theory, especially after the popularization of the academic view of spleen treatment, for diabetic patients who have just been diagnosed, especially patients with insulin resistance, Jinlida granules have shown unique curative advantages in treatment, and have played the concept of "prevention before illness, prevention is more important than cure" in traditional Chinese medicine.
-
Professor Yan Min commented on the PHILA study: Pyrrolidinib writes a new chapter on small molecule anti-HER2-positive advanced breast cancer
Time of Update: 2022-09-21
Professor Yan Min pointed out that the PHILA study released in the oral report of the recent ESMO annual meeting has been the third large-scale phase III study of pirroltinib, and its positive results add strength to the clinical application of pyrrolidinib in advanced breast cancer, and the THPy combination may provide a new choice for first-line treatment for patients with trastuzumab-sensitive HER2-positive advanced breast cancer.
-
Sika launches its new PURFORM® polyurethane technology
Time of Update: 2022-08-25
" Sika, the world's largest manufacturer of adhesives and sealants for the construction and automotive industries, has developed a new polyurethane technology and launched it on the market under the brand name PURFORM® .
-
The pharmaceutical sector is strong, and the approval of related ETF products is accelerating
Time of Update: 2022-08-15
[Pharmaceutical Network Pharmaceutical Stock Market] In recent days, the pharmaceutical index has continued to rise, and the industry believes that the next sector index may still have a certain upwa
-
Takeda China's First Rare Genetic and Blood Disorders Summit Successfully Held
Time of Update: 2022-05-02
The theme aims to create a national academic exchange platform, and join hands with relevant people from all walks of life such as clinical medicine, pharmacology, policy experts, and patient organization representatives to discuss core issues such as cutting-edge treatment plans for rare diseases, diagnosis and treatment system construction, and patient disease management.
-
JAMA latest: Over 50% of Chinese adults have diabetes or are in the pre-disease period
Time of Update: 2022-01-09
The paper pointed out that the current study is based on a large number of samples (170,287 and 173,642 subjects were included in the final analysis in 2013 and 2018), and it provides the latest statistics on the prevalence, treatment level, and risk factors of diabetes in China .
-
Health experts: Omi Keron strain appears to highlight inequality in vaccine distribution
Time of Update: 2021-12-02
Heide said that there are still many people in the world who have not been vaccinated against the new crown, such as in sub-Saharan Africa; the emergence of the Omi Keron strain is "a natural result of slow global vaccination .
-
Tan Desai warns of the emergence of a new virus beyond human control
Time of Update: 2021-11-11
According to a report from the Russian Satellite Network on the 30th, the Director-General of the World Health Organization Tan Desai warned that a new virus that cannot be controlled by humans may appear "at some time" and pointed out that it is necessary to strengthen the world.
-
Fudan scholars: PM2.5 exposure can cause increased secretion of human stress hormones
Time of Update: 2021-08-16
China News Service, August 16 (Reporter Chen Jing) Fudan University disclosed on the 16th that the research team of Professor Kan Haidong of the School of Public Health of the school has made new progress in the study of the health hazard mechanism of atmospheric fine particulate matter (PM2.
-
The 2020 Nobel Prize in Physiology or Medicine announced: the discovery of hepatitis C virus
Time of Update: 2021-08-08
The discoveries of the 2020 Nobel Prize winners in Physiology or Medicine have revealed the causes of the remaining cases of chronic hepatitis and made blood tests possible.
-
Kaili Medical brings new products to CMEF in the spring of 2021
Time of Update: 2021-07-06
Kailizhi "clear": 4K ultra-clear peak, crafted In the field of minimally invasive surgery, Kaili Medical combines its own advantages in optical design, image processing algorithms, cold light source design, and endoscope R&D and production to forcefully launch the 4K ultra-high-definition endoscopic camera system SV-M4K30, which has attracted much attention .
